Research obtained by a group of scientists shows the COVID vaccine spike protein can travel from the injection site and accumulate in organs and tissues including the spleen, bone marrow, the liver, adrenal glands and in “quite high concentrations” in the ovaries.
COVID vaccine researchers had previously assumed mRNA COVID vaccines would behave like traditional vaccines. The vaccine’s spike protein — responsible for infection and its most severe symptoms — would remain mostly in the injection site at the shoulder muscle or local lymph nodes.
But
new research obtained by a group of scientists contradicts that theory, a
Canadian cancer vaccine researcher said last week.
“We
made a big mistake. We didn’t realize it until now,” said Byram Bridle, a viral
immunologist and associate professor at University of Guelph, Ontario. “We
thought the spike protein was a great target antigen, we never knew the spike
protein itself was a toxin and was a pathogenic protein. So by vaccinating
people we are inadvertently inoculating them with a toxin.”
Bridle, who was awarded a $230,000 grant by the Canadian government last
year for research on COVID vaccine development, said he and a
group of international scientists filed a request for information from the
Japanese regulatory agency to get access to Pfizer’s “biodistribution study.”
Biodistribution
studies are used to determine where an injected compound travels in the body,
and which tissues or organs it accumulates in.
“It’s the first time ever scientists have been privy to seeing
where these messenger RNA [mRNA] vaccines go after
vaccination,” Bridle said in an interview with Alex Pierson where he
first disclosed the data. “Is it a safe assumption that it stays in the
shoulder muscle? The short answer is: absolutely not. It’s very disconcerting.”
The Sars-CoV-2
has a spike protein on its surface. That spike protein is what allows it to
infect our bodies, Bridle explained. “That is why we have been using the spike
protein in our vaccines,” Bridle said. “The vaccines we’re using get the cells
in our bodies to manufacture that protein. If we can mount an immune response
against that protein, in theory we could prevent this virus from infecting the
body. That is the theory behind the vaccine.”
“However, when studying the severe COVID-19, […] heart problems, lots of problems with the
cardiovascular system, bleeding and clotting, are all associated with
COVID-19,” he added. “In doing that research, what has been discovered by
the scientific community, the spike protein on its own is almost entirely
responsible for the damage to the cardiovascular system, if it gets into
circulation.”
When the purified spike protein is injected into the blood of
research animals, they experience damage to the cardiovascular system and the
protein can cross the blood-brain barrier and cause damage to the brain, Bridle explained.
The biodistribution study obtained
by Bridle shows the COVID spike protein gets into the blood where it circulates
for several days post-vaccination and then accumulates in organs and tissues
including the spleen, bone marrow, the liver, adrenal glands and in “quite high
concentrations” in the ovaries.
“We
have known for a long time that the spike protein is a pathogenic protein,
Bridle said. “It is a toxin. It can cause damage in our body if it gets into
circulation.”
A
large number of studies have shown the most severe effects of SARS-CoV-2,
the virus that causes COVID, such as blood clotting and bleeding, are due to
the effects of the spike protein of the virus itself.
A recent study in Clinical and Infectious Diseases led
by researchers at Brigham and Women’s Hospital and the Harvard Medical School
measured longitudinal plasma samples collected from 13 recipients of the Moderna vaccine 1 and 29 days after the
first dose and 1-28 days after the second dose.
Out of these individuals, 11 had detectable levels of
SARS-CoV-2 protein in blood plasma as early as one day after
the first vaccine dose, including three who had detectable levels of spike
protein. A “subunit” protein called S1, part of the spike protein, was also
detected.
Spike
protein was detected an average of 15 days after the first injection, and one
patient had spike protein detectable on day 29 — one day after a second vaccine
dose — which disappeared two days later.
The results showed S1
antigen production after the initial vaccination can be detected by day one and
is present beyond the injection site and the associated regional lymph nodes.
Assuming an average adult blood volume of approximately 5
liters, this corresponds to peak
levels of approximately 0.3 micrograms of circulating free antigen for a
vaccine designed only to express membrane-anchored antigen.
In a study published in Nature Neuroscience, lab animals injected with
purified spike protein into their bloodstream developed cardiovascular
problems. The spike protein also crossed the blood-brain barrier and caused
damage to the brain.
It
was a grave mistake to believe the spike protein would not escape into the
blood circulation, according to Bridle. “Now, we have clear-cut evidence that
the vaccines that make the cells in our deltoid muscles manufacture this
protein — that the vaccine itself, plus the protein — gets into blood
circulation,” he said.
Bridle
said the scientific community has discovered the spike protein, on its own, is
almost entirely responsible for the damage to the cardiovascular system, if it
gets into circulation.
Once
in circulation, the spike protein can attach to specific ACE2 receptors that
are on blood platelets and the cells that line blood vessels, Bridle said.
“When that happens it can do one of two things. It can either cause platelets
to clump, and that can lead to clotting — that’s exactly why we’ve been seeing
clotting disorders associated with these vaccines. It can also lead to
bleeding,” he added.
Both clotting and bleeding are associated with vaccine-induced thrombotic
thrombocytopenia (VITT). Bridle also said the spike
protein in circulation would explain recently reported heart problems in vaccinated
teens.
Stephanie
Seneff, senior research scientists at Massachusetts Institute of Technology,
said it is now clear vaccine content is being delivered to the spleen and the
glands, including the ovaries and the adrenal glands, and is being shed into
the medium and then eventually reaches the bloodstream causing systemic damage.
“ACE2
receptors are common in the heart and brain,” she added. “And this is how the
spike protein causes cardiovascular and cognitive problems.”
Dr. J. Patrick Whelan, a pediatric rheumatologist, warned the U.S. Food and Drug Administration (FDA)
in December mRNA vaccines could cause microvascular injury to the brain, heart,
liver and kidneys in ways not assessed in safety trials.
In a public submission, Whelan sought to alert the
FDA to the potential for vaccines designed to create immunity to the SARS-CoV-2
spike protein to instead cause injuries.
Whelan was concerned the mRNA vaccine technology utilized by Pfizer and Moderna had “the potential to cause
microvascular injury (inflammation and small blood clots called microthrombi)
to the brain, heart, liver and kidneys in ways that were not assessed in the
safety trials.”
Sign up for free news and updates from
Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many
strategies, including legal, in an effort to defend the health of our children
and obtain justice for those already injured. Your support is essential to CHD’s successful
mission.
Megan
Redshaw is a freelance reporter for The Defender. She has a background in
political science, a law degree and extensive training in natural health.
© [06/03/21] Children’s Health Defense, Inc. This work is reproduced and
distributed with the permission of Children’s Health Defense, Inc. Want to
learn more from Children’s Health Defense? Sign up for free news and updates
from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation
will help to support us in our efforts.
